Keywords: تری فلومونید; Multiple sclerosis; Teriflunomide; Gray matter; White matter; Brain atrophy; Diffusion-tensor imaging; Tract-based-spatial-statistics;
مقالات ISI تری فلومونید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تری فلومونید; Multiple sclerosis; Treatment; Interferon; Glatiramer acetate; Fumarates; Teriflunomide;
Keywords: تری فلومونید; Teriflunomide; Periodontitis; Dental caries; Leflunomide; Multiple sclerosis;
Keywords: تری فلومونید; Multiple sclerosis; Alemtuzumab; Dimethyl fumarate; Fingolimod; Natalizumab; Teriflunomide; Adverse effects; Depression; Anxiety; Systematic review;
Keywords: تری فلومونید; Multiple sclerosis; Dimethyl fumarate; Teriflunomide; Alemtuzumab;
Keywords: تری فلومونید; Nail loss; Teriflunomide; Multiple sclerosis; Treatment; Adverse events;
Keywords: تری فلومونید; Dimethyl fumarate (PubChem CID: 637568); teriflunomide (PubChem CID: 54684141); fingolimod (PubChem CID: 107970); Glatiramer acetate (PubChem CID: 3081884); Multiple sclerosis; Dimethyl fumarate; Teriflunomide; Fingolimod; Immunogenetics;
Keywords: تری فلومونید; Meta-analysis; Multiple sclerosis; Randomized controlled trial; Teriflunomide;
Keywords: تری فلومونید; Multiple sclerosis; Relapsing-remitting multiple sclerosis; Teriflunomide; Safety analysis; Clinical trials;
Keywords: تری فلومونید; multiple sclerosis; relapses; disease-modifying drugs; central nervous system; disability; magnetic resonance imaging; fingolimod; teriflunomide; dimethyl fumarate
Keywords: تری فلومونید; efficacy; multiple sclerosis; oral disease-modifying therapy; safety; teriflunomide;
Leflunomide: A promising drug with good antitumor potential
Keywords: تری فلومونید; Leflunomide; A771726; Teriflunomide; Anticancer drug; Therapeutic mechanisms;
Safety liver profile of teriflunomide versus interferon β in multiple sclerosis: Systematic review and indirect comparison meta-analysis
Keywords: تری فلومونید; Multiple sclerosis; Interferon β; Teriflunomide; Liver safety profile;
Anti-inflammatory drug, leflunomide and its metabolite teriflunomide inhibit NSCLC proliferation in vivo and in vitro
Keywords: تری فلومونید; Leflunomide; Teriflunomide; Apoptosis; NSCLC (non-small cell lung cancer); Microarray analysis;
Cost-utility of First-line Disease-modifying Treatments for Relapsing-Remitting Multiple Sclerosisâ
Keywords: تری فلومونید; cost-effectiveness; dimethyl fumarate; economic evaluation; glatiramer acetate; interferon-β; teriflunomide;
Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study
Keywords: تری فلومونید; AEs; adverse events; ALT; alanine aminotransferase; BL; baseline; CI; confidence interval; DMF; dimethyl fumarate; DMTs; disease-modifying therapies; EDSS; Expanded Disability Status Scale; ES; effect size; MedDRA; Medical Dictionary for Regulatory Activi
Novel electrospun nanofibrous matrices prepared from poly(lactic acid)/poly(butylene adipate) blends for controlled release formulations of an anti-rheumatoid agent
Keywords: تری فلومونید; Aliphatic polyesters; Electrospun nanofibers; Teriflunomide; Anti-rheumatoid; Patches; Controlled release;
Les nouveaux médicaments en neurologie
Keywords: تری فلومونید; antiépileptique; neurologie; pérampanel; sclérose en plaques; tafamidis; tériflunomide; transthyrétineantiepileptic; multiple sclerosis; neurology; perampanel; tafamidis; teriflunomide; transthyretin
Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
Keywords: تری فلومونید; Multiple sclerosis; Immune modulation; Treatment; Aubagio; Teriflunomide; Leflunomide;
Teriflunomide for the treatment of multiple sclerosis
Keywords: تری فلومونید; Teriflunomide; Multiple sclerosis; Immunotherapy; Oral
Intra-articular drug delivery from an optimized topical patch containing teriflunomide and lornoxicam for rheumatoid arthritis treatment: Does the topical patch really enhance a local treatment?
Keywords: تری فلومونید; Teriflunomide; Lornoxicam; Amine salt; Compound transdermal patch; Central composite design; Intra-articular drug delivery
Effect of the stability of hydrogen-bonded ion pairs with organic amines on transdermal penetration of teriflunomide
Keywords: تری فلومونید; Teriflunomide; Hydrogen-bonded ion pairs; FTIR; 1H NMR; Stability; Transdermal;
Immune mechanisms of new therapeutic strategies in MS — Teriflunomide
Keywords: تری فلومونید; Multiple sclerosis; Teriflunomide; Immune mechanism; Clinical trials
Biaryl analogues of teriflunomide as potent DHODH inhibitors
Keywords: تری فلومونید; DHODH inhibitors; Teriflunomide; Autoimmune diseases; RA; MS
Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC–MS/MS
Keywords: تری فلومونید; Teriflunomide; Leflunomide; LC–MS/MS; Rapid equilibration dialysis; Unbound drug concentration; Bioanalytical method validation
Emerging disease-modifying oral therapies for multiple sclerosis
Keywords: تری فلومونید; Multiple sclerosis (MS); Fingolimod (FTY720); Cladribine; Laquinimod (LAQ); Dimethylfumarate (BG00012); Teriflunomide
Promising Emerging Therapies for Multiple Sclerosis
Keywords: تری فلومونید; Alemtuzumab; Daclizumab; BG-12; Fumarate; Cladribine; Fingolimod; Laquinimod; Teriflunomide;
Chromatographic separation and sensitive determination of teriflunomide, an active metabolite of leflunomide in human plasma by liquid chromatography-tandem mass spectrometry
Keywords: تری فلومونید; Teriflunomide; LC–ESI-MS/MS; Human plasma; Bioequivalence study